The emergence of drug resistance in tumours: a characteristic which may be exploited therapeutically.
作者信息
Tattersall M H
出版信息
Br J Cancer. 1973 May;27(5):406-8. doi: 10.1038/bjc.1973.49.
Abstract
摘要
相似文献
1
The emergence of drug resistance in tumours: a characteristic which may be exploited therapeutically.肿瘤中耐药性的出现：一种可用于治疗的特性。
Br J Cancer. 1973 May;27(5):406-8. doi: 10.1038/bjc.1973.49.
2
3
Cytidine deaminase and the development of resistance to arabinosyl cytosine.胞苷脱氨酶与对阿糖胞苷耐药性的产生
Nat New Biol. 1971 Sep 22;233(38):109-10. doi: 10.1038/newbio233109a0.
4
Experimental and clinical studies on nucleoside analogs as antitumor agents.核苷类似物作为抗肿瘤药物的实验与临床研究
Ann N Y Acad Sci. 1975 Aug 8;255:202-12. doi: 10.1111/j.1749-6632.1975.tb29225.x.
5
Immunosuppressive activity of methotrexate and arabinosyl cytosine in mice bearing L1210 leukaemia.甲氨蝶呤和阿糖胞苷对荷L1210白血病小鼠的免疫抑制活性
Br J Pharmacol. 1968 Nov;34(3):674P-676P.
6
Reversal of resistance to methotrexate in L1210 murine leukemia by uracil.尿嘧啶逆转L1210小鼠白血病对甲氨蝶呤的耐药性
Blood. 1971 Nov;38(5):648-56.
7
8
[Molecular mechanisms of cellular resistance to antifolates].[细胞对抗叶酸药物耐药的分子机制]
Postepy Biochem. 1983;29(2):167-90.
9
Studies of the L1210 antileukemic activity of O-2,2'-cyclocytidine, monoacetate (anhydro-ara-C; NSC-129220)--comparison with cytosine arabinoside (NSC-63878) with respect to treatment schedule dependency.O-2,2'-环胞苷单乙酸酯（脱水阿糖胞苷；NSC-129220）的L1210抗白血病活性研究——关于治疗方案依赖性与阿糖胞苷（NSC-63878）的比较
Cancer Chemother Rep. 1972 Aug;56(4):483-92.
引用本文的文献
1
Combination chemotherapy.联合化疗
Proc R Soc Med. 1974 Jun;67(6 Pt 1):434-6. doi: 10.1177/00359157740676P103.
2
Blood and neoplastic diseases. Rational approach to the chemotherapy of human malignant disease-II.血液与肿瘤疾病。人类恶性疾病化疗的合理方法 - 二。
Br Med J. 1974 Oct 26;4(5938):216-8. doi: 10.1136/bmj.4.5938.216.
本文引用的文献
1
2
Inhibition of dihydrofolic reductase by aminopterin and amethopterin.氨蝶呤和甲氨蝶呤对二氢叶酸还原酶的抑制作用。
Proc Soc Exp Biol Med. 1958 Feb;97(2):429-31. doi: 10.3181/00379727-97-23764.
3
Fluorinated pyrimidines, a new class of tumour-inhibitory compounds.氟化嘧啶，一类新型的肿瘤抑制化合物。
Nature. 1957 Mar 30;179(4561):663-6. doi: 10.1038/179663a0.
4
The metabolism of 5-fluorocytosine-2-14-C and of cytosine-14-C in the rat and the disposition of 5-fluorocytosine-2-14-C in man.5-氟胞嘧啶-2-¹⁴C和胞嘧啶-¹⁴C在大鼠体内的代谢以及5-氟胞嘧啶-2-¹⁴C在人体内的分布。
Biochem Pharmacol. 1966 Apr;15(4):435-46. doi: 10.1016/0006-2952(66)90254-1.
5
6
5-fluorocytosine in the treatment of cryptococcal and candida mycoses.5-氟胞嘧啶治疗隐球菌和念珠菌感染性真菌病
Ann Intern Med. 1971 Apr;74(4):535-9. doi: 10.7326/0003-4819-74-4-535.
7
Cytidine deaminase and the development of resistance to arabinosyl cytosine.胞苷脱氨酶与对阿糖胞苷耐药性的产生
Nat New Biol. 1971 Sep 22;233(38):109-10. doi: 10.1038/newbio233109a0.
8
Phase I study of high doses of methotrexate with citrovorum factor in patients with lung cancer.
Cancer. 1972 Jul;30(1):22-30. doi: 10.1002/1097-0142(197207)30:1<22::aid-cncr2820300105>3.0.co;2-b.
9
Further evaluation of the antitumor activity of homofolate and its reduced derivatives against methotrexate-insensitive tumors.
Chemotherapy. 1972;17(4):283-92. doi: 10.1159/000220859.
10
Zotero 插件